Official Publications Theraclion

Equities

Market Closed - Euronext Paris Other stock markets 16:08:39 31/05/2024 BST			5-day change	1st Jan Change
0.365 ^EUR	+1.39%		-13.10%	-5.93%

03-27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Combined general shareholders meeting	23/05/23	CO
Monthly statement on voting rights	29/04/23	CO
Annual results	27/04/23	CO
Annual results	27/04/23	CO
Financial report	27/04/23	CO
Monthly statement on voting rights	30/03/23	CO
Monthly statement on voting rights	27/02/23	CO
Monthly statement on voting rights	30/01/23	CO
Monthly statement on voting rights	29/11/22	CO
Half-year report	31/10/22	CO
Monthly statement on voting rights	30/10/22	CO
Changes in management and corporate officers	30/10/22	CO
1st-half-year results	25/09/22	CO
1st-half-year results	25/09/22	CO
Monthly statement on voting rights	30/07/22	CO
Monthly statement on voting rights	29/06/22	CO
Monthly statement on voting rights	30/05/22	CO
Monthly statement on voting rights	29/04/22	CO
Monthly statement on voting rights	30/03/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	06/03/22	CO
Corporate officers' Statement : -Other Types Operations	06/03/22	CO
Corporate officers' Statement : -Other Types Operations	02/03/22	CO
Corporate officers' Statement -: xercise of Stock Options 4	01/03/22	CO
Minutes of the general assembly	06/02/22	CO
Monthly statement on voting rights	30/01/22	CO